$SSII
SS Innovations International, Inc. Stock $ssii

$ssii Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023085569 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$1.363M	$1.430M	$0.00
YoY Change
Cost Of Revenue	$1.545M	$1.270M	$315.7K
YoY Change	389.32%	75.17%	134.12%
Gross Profit	-$181.7K	$159.8K	-$315.7K
YoY Change	-42.44%	-122.05%	134.12%
Gross Profit Margin	-13.33%	11.18%
Selling, General & Admin	$15.27M	$1.275M	$908.3K
YoY Change	1581.57%	627.86%	541.8%
% of Gross Profit		797.69%
Research & Development	$576.2K	$293.1K	$72.96K
YoY Change	689.71%
% of Gross Profit		183.36%
Depreciation & Amortization	-$64.60K	-$83.68K	$2.280K
YoY Change	-2933.33%	-3786.34%	-23.49%
% of Gross Profit		-52.35%
Operating Expenses	$15.85M	$2.132M	$981.2K
YoY Change	1515.25%	136.88%	593.41%
Operating Profit	-$16.03M	-$1.972M	-$1.297M
YoY Change	1136.04%	21.37%	369.29%
Interest Expense	-$208.3K	-$11.48K	-$45.49K
YoY Change	357.97%	-28800.0%	-151733.33%
% of Operating Profit
Other Income/Expense, Net	$120.0K	-$11.48K	$170.0K
YoY Change	-29.4%	-110.43%	-319.64%
Pretax Income	-$16.12M	-$1.984M	-$1.172M
YoY Change	1274.82%	151.1%	231.46%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$16.12M	-$1.984M	-$1.172M
YoY Change	1274.82%	151.1%	231.46%
Net Earnings / Revenue	-1182.44%	-138.76%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	-$0.10	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	169.1M shares	146.2M shares	39.20M shares
Diluted Shares Outstanding		146.7M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.022M	$6.596M	$1.351M
YoY Change	49.65%	1182.96%	233.04%
Cash & Equivalents	$2.022M	$6.596M	$1.351M
Short-Term Investments
Other Short-Term Assets	$8.386M	$7.049M	$8.680K
YoY Change	96511.75%	33337.24%	279.04%
Inventory	$6.327M	$4.171M
Prepaid Expenses
Receivables	$1.647M	$1.512M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$18.38M	$19.33M	$4.360M
YoY Change	321.62%	1081.98%	968.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$790.2K	$661.6K	$11.40K
YoY Change	6831.87%	4736.83%	-44.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$7.096M	$4.731M	$11.40K
YoY Change	62154.46%	34488.14%	-44.51%
TOTAL ASSETS
Total Short-Term Assets	$18.38M	$19.33M	$4.360M
Total Long-Term Assets	$7.096M	$4.731M	$11.40K
Total Assets	$25.48M	$24.06M	$4.371M
YoY Change	482.85%	1359.09%	919.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$900.9K	$175.8K
YoY Change		168.06%
Accrued Expenses	$2.330M	$1.996M	$5.700K
YoY Change	40783.51%	34912.63%	-67.8%
Deferred Revenue	$156.3K
YoY Change
Short-Term Debt	$6.019M	$6.118M	$4.000M
YoY Change	50.47%	456.2%
Long-Term Debt Due	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$9.271M	$8.296M	$4.051M
YoY Change	128.84%	530.28%	1310.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.910M	$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$1.910M	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.271M	$8.296M	$4.051M
Total Long-Term Liabilities	$1.910M	$0.00	$0.00
Total Liabilities	$11.18M	$8.296M	$4.051M
YoY Change	175.99%	530.28%	1310.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$35.33M	-$21.09M	-$10.69M
YoY Change	230.46%	121.52%	26.1%
Common Stock	$17.07K	$36.21M	$5.389K
YoY Change	216.77%	886780.87%	42.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.30M	$15.76M	$320.2K
YoY Change
Total Liabilities & Shareholders Equity	$25.48M	$24.06M	$4.371M
YoY Change	482.85%	1359.09%	919.92%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$16.12M	-$1.984M	-$1.172M
YoY Change	1274.82%	151.1%	231.46%
Depreciation, Depletion And Amortization	-$64.60K	-$83.68K	$2.280K
YoY Change	-2933.33%	-3786.34%	-23.49%
Cash From Operating Activities	$258.3K	-$3.152M	-$1.132M
YoY Change	-122.81%	3525.41%	887.72%
INVESTING ACTIVITIES
Capital Expenditures	$1.886M	$141.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$4.533M	-$3.298M	-$1.900M
YoY Change	-338.6%	199.8%	-7407.69%
Cash From Investing Activities	$2.647M	-$3.439M	-$1.900M
YoY Change	-239.34%	212.66%	-7407.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.288M	12.76M	3.869M
YoY Change	-288.35%	786.41%	1237.95%
NET CHANGE
Cash From Operating Activities	258.3K	-3.152M	-1.132M
Cash From Investing Activities	2.647M	-3.439M	-1.900M
Cash From Financing Activities	-7.288M	12.76M	3.869M
Net Change In Cash	-4.382M	6.173M	837.2K
YoY Change	-623.4%	2339.41%	317.4%
FREE CASH FLOW
Cash From Operating Activities	$258.3K	-$3.152M	-$1.132M
Capital Expenditures	$1.886M	$141.4K
Free Cash Flow	-$1.628M	-$3.293M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56608
	dei	Entity Registrant Name EntityRegistrantName	SS INNOVATIONS INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3478854
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1500 SE 15th Street,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#512,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Lauderdale,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33316
	dei	City Area Code CityAreaCode	(954)
	dei	Local Phone Number LocalPhoneNumber	478-1410
	dei	Security12b Title Security12bTitle	None
	dei	Trading Symbol TradingSymbol	N/A
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	169118385	shares
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6596224	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1351364	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1512055	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3000000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4171178	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7048574	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8678	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	19328031	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4360042	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	661582	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11399	usd
CY2023Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2209050	usd
CY2023Q3	ssii	Loans Advances Related Party LoansAdvancesRelatedParty	1860333	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	4730966	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11399	usd
CY2023Q3	us-gaap	Assets Assets	24058996	usd
CY2022Q4	us-gaap	Assets Assets	4371441	usd
CY2023Q3	us-gaap	Bank Overdrafts BankOverdrafts	6118214	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4000000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	175808	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6603	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1995716	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	51229	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8296341	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4051229	usd
CY2023Q3	us-gaap	Liabilities Liabilities	8296341	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4051229	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	169117202	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	169117202	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53887738	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53887738	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	16911	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5389	usd
CY2023Q3	ssii	Translation Adjustment TranslationAdjustment	-262646	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36194435	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11005895	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	899917	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21085962	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10691071	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15762655	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	320213	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24058996	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4371441	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	1269928	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	159844	usd
CY2022Q3	ssii	Compensation Expense CompensationExpense	724965	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	857243	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1275062	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	175180	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2132306	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	900145	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1972462	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-900145	usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	42	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11478	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	110000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11478	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	110042	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1983940	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-790104	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1983940	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	790104	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	169627122	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39461725	shares
	us-gaap	Cost Of Revenue CostOfRevenue	3621275	usd
	us-gaap	Gross Profit GrossProfit	895182	usd
	ssii	Compensation Expense CompensationExpense	1592309	usd
	ssii	Compensation Expense CompensationExpense	819732	usd
	us-gaap	Salaries And Wages SalariesAndWages	2293888	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1646121	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	330900	usd
	us-gaap	Operating Expenses OperatingExpenses	5532319	usd
	us-gaap	Operating Expenses OperatingExpenses	1150632	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4637136	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1150632	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	106	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-185269	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	110000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-185269	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	110106	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4822406	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1040525	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4822406	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1040525	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	114855607	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	38471501	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	320213	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1597693	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	432672	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1155	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2004320	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	347414	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6138541	usd
CY2023Q2	ssii	Recapitalization One RecapitalizationOne	-4556208	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	742271	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1850423	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	821595	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16980000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-105000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1983940	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15762655	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	141326	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	27476	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	764	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-80421	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	89145	usd
CY2022Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	25189	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72081	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	41337	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-170001	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	57751	usd
CY2022Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	616349	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	511985	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	26000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-89368	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-790104	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	332612	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4822406	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1040525	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	227219	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6864	usd
	us-gaap	Interest Expense InterestExpense	25315	usd
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	262646	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12723129	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1597693	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	819732	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2126898	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-89782	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13831054	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-303711	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	4069383	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	877403	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4946786	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	6118214	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	446188	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	412080	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12360	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	22980000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000	usd
	ssii	Recapitalization Recapitalization	-4559341	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-1000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24022701	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	412080	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5244861	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	108369	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1351364	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	405774	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6596224	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	514143	usd
	ssii	Working Capital Deficit WorkingCapitalDeficit	11031690	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21085962	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4822406	usd
	ssii	Aggregate Amounts AggregateAmounts	20000000	usd
CY2023Q3	ssii	Aggregate Amounts AggregateAmounts	16980000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15760000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	821595	usd
	ssii	Working Capital Deficit WorkingCapitalDeficit	2880000	usd
CY2023Q3	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	50000	usd
	us-gaap	Payments For Deposits PaymentsForDeposits	6263878	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	14029170	shares
	ssii	Provided Interim Financing ProvidedInterimFinancing	3000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. The Company regularly evaluates estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates made by management.</p>
CY2023Q3	ssii	Foreign Currency Closing Rate Translation ForeignCurrencyClosingRateTranslation	83.09	pure
CY2023Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	82.575	pure
CY2023Q3	us-gaap	Inventory Net InventoryNet	4171178	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its principal cash balance in United States financial institutions, where deposits are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company also maintains cash balances maintained with banks in India, where balances are insured by Deposit Insurance and Credit Guarantee Corporation of India (DICGC) to the extent of approximately US$ 6,100 per account and in the Bahamas, where deposits are insured by the Deposit Insurance Corporation of Bahamas insures deposits up to US$50,000 per account. As at September 30,2023, $ 6,263,878 of deposits were in excess of overall insurance coverage limits.</p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	6100	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	1355448	usd
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000	usd
CY2023Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.07	pure
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1012116	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	134714	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	350534	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	123315	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	661582	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11399	usd
	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	227599	usd
	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	6864	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	1512055	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1512055	usd
CY2023Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	2209050	usd
CY2023Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2209050	usd
	ssii	Deferred Payment Terms DeferredPaymentTerms	2209050	usd
CY2022Q2	ssii	Stock Issued During Period Security Offerings StockIssuedDuringPeriodSecurityOfferings		usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	175808	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1995716	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	51229	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2171524	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	51229	usd
CY2023Q2	ssii	Working Capital WorkingCapital	20000000	usd
CY2023Q3	us-gaap	Assets Average Outstanding AssetsAverageOutstanding	16980000	usd
CY2023Q3	us-gaap	Shares Issued SharesIssued	22945946	shares
CY2023Q3	us-gaap	Bank Overdrafts BankOverdrafts	6118214	usd
CY2023Q3	us-gaap	Deposit Assets DepositAssets	4827882	usd
CY2023Q3	us-gaap	Deposits Deposits	4964496	usd
CY2023Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	135808884	shares
	ssii	Common Stock Ownership Percentage CommonStockOwnershipPercentage	0.95	pure
	ssii	Exercise Percentage exercisePercentage	0.51	pure
	ssii	Preferred Shares Percentage PreferredSharesPercentage	0.50	pure
CY2023Q3	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	250000000	shares
	ssii	Aggregate Shares AggregateShares	10149232	shares
	ssii	Royalty Percentage RoyaltyPercentage	0.03	pure
CY2023Q2	us-gaap	Capital Units Total Cost To Investors CapitalUnitsTotalCostToInvestors	3000000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	16980000	usd
CY2023Q3	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	22945946	shares
CY2023Q3	us-gaap	Preferred Stock Convertible Conversion Price Increase PreferredStockConvertibleConversionPriceIncrease	0.74
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1829.25	usd
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2454.75	usd
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2223	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1474.17	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	404.68	usd
CY2023Q3	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	194	usd
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16528	usd
	ssii	Lease Expiration Date LeaseExpirationDate	March 2030
CY2023Q3	us-gaap	Area Of Land AreaOfLand	21600	sqm
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16349	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1860333	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
CY2023Q3	us-gaap	Other Loans Payable OtherLoansPayable	1860333	usd
CY2023Q3	us-gaap	Loans Payable LoansPayable	1860333	usd
CY2023Q2	us-gaap	Related Party Transaction Date RelatedPartyTransactionDate	2023-12-31
CY2023Q2	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	20000000	usd
	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.74
CY2023Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1225000	usd
	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	15755000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	16980000	usd
CY2023Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	16980000	usd
CY2023Q3	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	0.74
CY2023Q3	us-gaap	Common Unit Issued CommonUnitIssued	22945946	shares
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	ssii	Loans Advances Related Party LoansAdvancesRelatedParty		usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts		usd
CY2023Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent		usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent		usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	ssii	Translation Adjustment TranslationAdjustment		usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q3	us-gaap	Gross Profit GrossProfit		usd
CY2023Q3	ssii	Compensation Expense CompensationExpense		usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages		usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Salaries And Wages SalariesAndWages		usd
	us-gaap	Investment Income Net InvestmentIncomeNet		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	ssii	Stock Issued During Period Security Offerings StockIssuedDuringPeriodSecurityOfferings		usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod		usd
CY2023Q2	ssii	Recapitalization Recapitalization		usd
CY2023Q3	ssii	Exercise Of Options1 ExerciseOfOptions1		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q1	ssii	Stock Issued During Period Security Offerings StockIssuedDuringPeriodSecurityOfferings		usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod		usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment		usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan		usd
	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan		usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	ssii	Recapitalization Recapitalization		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q3	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	1698000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts		usd
CY2022Q4	us-gaap	Loans Payable LoansPayable		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001676163
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes

Files In Submission

Name	View Source	Status
0001213900-23-085569-index-headers.html	Edgar Link	pending
0001213900-23-085569-index.html	Edgar Link	pending
0001213900-23-085569.txt	Edgar Link	pending
0001213900-23-085569-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_ssinnovation.htm	Edgar Link	pending
f10q0923ex31-2_ssinnovation.htm	Edgar Link	pending
f10q0923ex32-1_ssinnovation.htm	Edgar Link	pending
f10q0923ex32-2_ssinnovation.htm	Edgar Link	pending
f10q0923_ssinnovation.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_ssinnovation_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssii-20230930.xsd	Edgar Link	pending
ssii-20230930_cal.xml	Edgar Link	unprocessable
ssii-20230930_def.xml	Edgar Link	unprocessable
ssii-20230930_lab.xml	Edgar Link	unprocessable
ssii-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSII
SS Innovations International, Inc. Stock $ssii

2023 Q4 Form 10-Q Financial Statement

#000121390023085569 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII SS Innovations International, Inc. Stock $ssii

2023 Q4 Form 10-Q Financial Statement

#000121390023085569 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII
SS Innovations International, Inc. Stock $ssii